GYNECOLOGICAL MALIGNANCIES
Clinical trials for GYNECOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new GYNECOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for GYNECOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat gynecologic cancers in early trial
Disease control Recruiting nowThis study tests an experimental drug called BL-M07D1 in people with HER2-positive gynecologic cancers (like ovarian or uterine) that have come back or spread and no longer respond to standard treatments. About 138 participants will receive the drug to see if it can shrink tumors…
Matched conditions: GYNECOLOGICAL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Blood test may predict immunotherapy success in Women's cancers
Knowledge-focused Recruiting nowThis study looks at whether changes in a blood marker called CRP can help predict how well immunotherapy works in women with advanced gynecologic cancers (cervical, endometrial, ovarian, or vulvar). Researchers will track CRP levels in 120 women receiving immunotherapy plus chemo…
Matched conditions: GYNECOLOGICAL MALIGNANCIES
Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC